Market News & Trends
Patheon Selected By Grünenthal to Develop Drugs Using INTAC(R) Abuse-Deterrent Formulations Technology
Patheon, the leading global provider of pharmaceutical development and manufacturing services today announced it has signed a strategic agreement with Grünenthal, an independent, family-owned,…
AAI Pharma Services Corporation & Cambridge Major Laboratories Are Now Alcami
AAIPharma Services Corporation (AAI) / Cambridge Major Laboratories, Inc. (CML), a leading provider of custom development and manufacturing services for the pharmaceutical and biotechnology industries, recently announced its…
Aptar Pharma Launches eDose Counter for MDIs Integrating Proprietary Sensing Technology
Aptar Pharma, a global solution provider of innovative and proven aerosol, injection, and spray delivery systems for biotech, healthcare, and pharma products, will unveil…
Genomics plc & DNAnexus Collaborate to Develop Solutions for Population-Scale Sequencing Analysis
Genomics plc recently announced it has entered into a research collaboration with DNAnexus, the global leader in cloud-based genome informatics and data management. The companies…
Actinium Announces Selection of Zevacor for Clinical Production & Supply Pivotal Phase III Trial
Actinium Pharmaceuticals, Inc. recently announced the company has entered into an agreement with Zevacor Pharma, Inc. (formerly IBA Molecular North America, Inc.) for the clinical…
FDA Accepts for Priority Review Bristol-Myers Squibb’s Supplemental Biologics License Application for Opdivo
Bristol-Myers Squibb Company recently announced the US FDA accepted a supplemental Biologics License Application (sBLA), which seeks to expand the use of Opdivo to patients…
Presage Biosciences Extends Research Collaboration With Takeda
Presage Biosciences recently announced it has entered into a multi-year extension of its November 2014 research alliance with Takeda Pharmaceuticals Company Limited. The agreement provides…
Pluristem Continues to Strengthen its Position in Japan; Granted Two Key
Pluristem Therapeutics Inc. recently announced that the Japan Patent Office has granted the Company two key patents addressing: 1) Pluristem’s core technology of three-dimensional expansion…
N-of-One Selected by Admera Health to Provide Clinical Interpretation for the OncoGxOne 64-Gene Oncology Panel
N-of-One, Inc. recently announced that Admera Health has selected N-of-One to provide clinical interpretation of their 64-gene oncology panel, OncoGxOne. N-of-One’s patient-specific analysis is based…
World Excipients Market Expected to Reach $6.4 Billion by 2020
A new report published by Allied Market Research titled World Excipients Market-Opportunities and Forecasts, 2014-2020 projects that the world excipients market would reach $6.4 billion…
Global Viral Infections Market to Reach $117.6 Billion
The global viral infections market will grow from $74 billion in 2014 to $117.6 billion by 2021, representing a compound annual growth rate of 6.8%,…
REMD Biotherapeutics Announces Dosing of First Type 1 Diabetes Patient With Glucagon Receptor Monoclonal Antibody
REMD Biotherapeutics, Inc., together with its subsidiary, Beijing CoSci-REMD Bio Med-Tech Co, Ltd (CoSci-REMD Bio), recently announced that the first patient with type 1 diabetes…
Labome Releases Validated Antibody Database Version 2.2
Antibodies form an essential part of the immune defence against microbes and have been explored as therapeutics and diagnostics due to their ability to bind…
Human Vaccines Project Launches San Diego Research Hub
Four scientific institutions – University of California, San Diego, J. Craig Venter Institute, La Jolla Institute for Allergy and Immunology and The Scripps Research Institute…
Galapagos Initiates Phase IIa Study
Galapagos NV recently announced the start of its exploratory Phase IIa study with GLPG1690 in idiopathic pulmonary fibrosis (IPF) patients, named FLORA, a randomized, double-blind,…
New Study Finds Thousands of PE Patients May Later Develop Life-Threatening Form of PH
Results from a retrospective claims database study of pulmonary embolism (PE) patients published today in the American Journal of Medicine indicate that US physicians may…
Adaptimmune Announces FDA Acceptance of IND Application
Adaptimmune Therapeutics plc recently announced that the US FDA has accepted the company’s investigational new drug (IND) application for autologous genetically modified T-cells expressing affinity…
WellSpring Pharma Services Completes $3-Million Capital Investment & Forms New Partnership
WellSpring Pharma Services, leading specialists in formulation, development and manufacturing for a wide range of solid, semi-solid and non-sterile liquid products, has announced a $3…
Paragon Bioservices Recognized as Best Contract Manufacturing Organization
Paragon Bioservices, Inc., a global leader in the manufacturing of biopharmaceuticals and vaccines, announced today that it was selected as the "Best Contract Manufacturing Organization"…
Crown Bioscience Strengthens Immuno-Oncology Capabilities With HuGEMM
Crown Bioscience, a wholly owned subsidiary of Crown Bioscience International (TWSE: ticker 6554), a global drug discovery and development services company providing translational platforms to…
